Back

eXoZymes shares fall 4.86% to $6.50 after Curia manufacturing deal

Verifying
  • eXoZymes signed a commercial-scale development and manufacturing agreement with Curia Global for NCT.
  • 4.86%: EXOZ traded at $6.50 after the agreement announcement.
  • Q4 2026: The program will guide larger-scale NCT production planning for 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.